Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Schall Thomas J.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Schall Thomas J. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:IMRX / Immuneering Corporation | Director | 52 885 |
US:CCXI / ChemoCentryx Inc | President and CEO, Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Schall Thomas J.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IMRX / Immuneering Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IMRX / Immuneering Corporation. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IMRX / Immuneering Corporation. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Schall Thomas J. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-30 |
|
4 | IMRX |
Immuneering Corp
Class A Common Stock |
P - Purchase | 9 500 | 52 885 | 21,90 | 3,66 | 34 788 | 193 660 | |
2025-06-18 |
|
4 | IMRX |
Immuneering Corp
Class A Common Stock |
P - Purchase | 40 485 | 43 385 | 1 396,03 | 2,21 | 89 278 | 95 673 | |
2024-03-25 |
|
4 | IMRX |
Immuneering Corp
Class A Common Stock |
P - Purchase | 2 900 | 2 900 | 2,55 | 7 385 | 7 385 | ||
2022-10-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
D - Sale to Issuer | −2 393 352 | 0 | −100,00 | ||||
2022-08-08 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −130 000 | 2 393 352 | −5,15 | 50,24 | −6 531 733 | 120 251 817 |
2022-08-08 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 130 000 | 2 523 352 | 5,43 | 14,28 | 1 856 400 | 36 033 467 | |
2022-02-25 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 192 600 | 192 600 | |||||
2022-02-25 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
A - Award | 152 700 | 152 700 | |||||
2022-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −26 333 | 52 667 | −33,33 | ||||
2022-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −34 567 | 34 567 | −50,00 | ||||
2022-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −23 334 | 0 | −100,00 | ||||
2022-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
F - Taxes | −45 698 | 2 393 352 | −1,87 | 36,41 | −1 663 864 | 87 141 946 | |
2022-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 26 333 | 2 439 050 | 1,09 | ||||
2022-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 34 567 | 2 412 717 | 1,45 | ||||
2022-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 23 334 | 2 378 150 | 0,99 | ||||
2021-12-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −6 988 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −38 948 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 6 988 | 2 354 816 | 0,30 | 14,31 | 99 998 | 33 697 417 | |
2021-12-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 38 948 | 2 347 828 | 1,69 | 10,27 | 399 996 | 24 112 194 | |
2021-03-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 54 600 | 54 600 | |||||
2021-03-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
A - Award | 79 000 | 79 000 | |||||
2021-01-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −34 566 | 69 134 | −33,33 | ||||
2021-01-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −23 333 | 23 334 | −50,00 | ||||
2021-01-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2021-01-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
F - Taxes | −47 576 | 2 308 880 | −2,02 | 61,92 | −2 945 906 | 142 965 850 | |
2021-01-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 34 566 | 2 356 456 | 1,49 | ||||
2021-01-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 23 333 | 2 321 890 | 1,02 | ||||
2021-01-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 30 000 | 2 298 557 | 1,32 | ||||
2020-12-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −17 619 | 6 988 | −71,60 | ||||
2020-12-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −17 619 | 2 268 557 | −0,77 | 65,01 | −1 145 450 | 147 483 881 |
2020-12-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 17 619 | 2 286 176 | 0,78 | 14,31 | 252 128 | 32 715 179 | |
2020-12-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −11 153 | 24 607 | −31,19 | ||||
2020-12-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −11 153 | 2 268 557 | −0,49 | 65,03 | −725 246 | 147 517 456 |
2020-12-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 11 153 | 2 279 710 | 0,49 | 14,31 | 159 599 | 32 622 650 | |
2020-06-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 35 760 | −5,30 | ||||
2020-06-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −2 000 | 2 268 557 | −0,09 | 65,04 | −130 090 | 147 557 836 |
2020-06-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 2 000 | 2 270 557 | 0,09 | 14,31 | 28 620 | 32 491 671 | |
2020-06-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −88 753 | 37 760 | −70,15 | ||||
2020-06-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −88 753 | 2 268 557 | −3,77 | 65,08 | −5 775 877 | 147 633 379 |
2020-06-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 88 753 | 2 357 310 | 3,91 | 14,31 | 1 270 055 | 33 733 106 | |
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −35 865 | 126 513 | −22,09 | ||||
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −35 865 | 2 268 557 | −1,56 | 57,75 | −2 071 100 | 131 002 588 |
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 35 865 | 2 304 422 | 1,58 | 14,31 | 513 228 | 32 976 279 | |
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −70 608 | 162 378 | −30,31 | ||||
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −16 029 | 2 268 557 | −0,70 | 56,14 | −899 874 | 127 357 697 |
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −54 579 | 2 284 586 | −2,33 | 55,33 | −3 019 856 | 126 406 143 |
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 70 608 | 2 339 165 | 3,11 | 14,31 | 1 010 400 | 33 473 451 | |
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −4 201 | 232 986 | −1,77 | ||||
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −4 201 | 2 268 557 | −0,18 | 55,01 | −231 115 | 124 802 849 |
2020-05-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 4 201 | 2 272 758 | 0,19 | 14,31 | 60 116 | 32 523 167 | |
2020-05-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −8 851 | 237 187 | −3,60 | ||||
2020-05-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −8 851 | 2 268 557 | −0,39 | 55,01 | −486 851 | 124 782 431 |
2020-05-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 8 851 | 2 277 408 | 0,39 | 14,31 | 126 658 | 32 589 708 | |
2020-03-05 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −40 844 | 246 038 | −14,24 | ||||
2020-03-05 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −40 844 | 2 268 557 | −1,77 | 50,35 | −2 056 691 | 114 232 734 |
2020-03-05 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 40 844 | 2 309 401 | 1,80 | 14,31 | 584 478 | 33 047 528 | |
2020-03-05 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 71 500 | 71 500 | |||||
2020-03-05 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
A - Award | 103 700 | 103 700 | |||||
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −15 341 | 286 882 | −5,08 | ||||
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −29 | 2 268 557 | 0,00 | 51,10 | −1 482 | 115 923 263 |
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −15 312 | 2 268 586 | −0,67 | 50,21 | −768 814 | 113 905 476 |
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 15 341 | 2 283 898 | 0,68 | 14,31 | 219 530 | 32 682 580 | |
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −63 340 | 302 223 | −17,33 | ||||
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −7 723 | 2 268 557 | −0,34 | 51,14 | −394 977 | 116 020 811 |
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −55 617 | 2 276 280 | −2,39 | 50,41 | −2 803 536 | 114 742 495 |
2020-02-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 63 340 | 2 331 897 | 2,79 | 14,31 | 906 395 | 33 369 446 | |
2020-02-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −119 525 | 365 563 | −24,64 | ||||
2020-02-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −119 525 | 2 268 557 | −5,01 | 45,18 | −5 400 701 | 102 504 067 |
2020-02-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 119 525 | 2 388 082 | 5,27 | 14,31 | 1 710 403 | 34 173 453 | |
2020-01-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −105 735 | 38 948 | −73,08 | ||||
2020-01-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −22 179 | 2 268 557 | −0,97 | 42,13 | −934 399 | 95 574 080 |
2020-01-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −83 556 | 2 290 736 | −3,52 | 41,46 | −3 463 872 | 94 964 064 |
2020-01-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 105 735 | 2 374 292 | 4,66 | 10,27 | 1 085 898 | 24 383 979 | |
2020-01-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −30 317 | 144 683 | −17,32 | ||||
2020-01-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −30 317 | 2 268 557 | −1,32 | 41,01 | −1 243 170 | 93 023 768 |
2020-01-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 30 317 | 2 298 874 | 1,34 | 10,27 | 311 356 | 23 609 436 | |
2020-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −23 333 | 46 667 | −33,33 | ||||
2020-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −30 000 | 30 000 | −50,00 | ||||
2020-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −33 334 | 0 | −100,00 | ||||
2020-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
F - Taxes | −46 965 | 2 268 557 | −2,03 | 39,55 | −1 857 466 | 89 721 429 | |
2020-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 23 333 | 2 315 522 | 1,02 | ||||
2020-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 30 000 | 2 292 189 | 1,33 | ||||
2020-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 33 334 | 2 262 189 | 1,50 | ||||
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −279 166 | 0 | −100,00 | ||||
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 500 | 2 228 855 | −0,07 | 35,60 | −53 393 | 79 336 762 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −54 936 | 2 230 355 | −2,40 | 34,69 | −1 905 477 | 77 360 755 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −29 290 | 2 285 291 | −1,27 | 33,86 | −991 633 | 77 370 127 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −14 969 | 2 314 581 | −0,64 | 32,65 | −488 726 | 75 569 218 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −32 780 | 2 329 550 | −1,39 | 31,76 | −1 041 076 | 73 985 343 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −78 581 | 2 362 330 | −3,22 | 30,78 | −2 419 116 | 72 724 329 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −31 335 | 2 440 911 | −1,27 | 29,23 | −915 869 | 71 343 679 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −14 134 | 2 472 246 | −0,57 | 28,44 | −401 955 | 70 307 957 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −21 641 | 2 486 380 | −0,86 | 27,30 | −590 866 | 67 885 882 |
2019-11-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 279 166 | 2 508 021 | 12,53 | 6,30 | 1 758 746 | 15 800 532 | |
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −74 986 | 0 | −100,00 | ||||
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −74 986 | 2 228 855 | −3,25 | 13,85 | −1 038 909 | 30 880 117 |
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 74 986 | 2 303 841 | 3,36 | 6,00 | 449 916 | 13 823 046 | |
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −79 259 | 74 986 | −51,39 | ||||
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −79 259 | 2 228 855 | −3,43 | 13,58 | −1 076 084 | 30 260 719 |
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 79 259 | 2 308 114 | 3,56 | 6,00 | 475 554 | 13 848 684 | |
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −5 755 | 154 245 | −3,60 | ||||
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −5 755 | 2 228 855 | −0,26 | 14,00 | −80 570 | 31 203 970 |
2019-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 5 755 | 2 234 610 | 0,26 | 6,00 | 34 530 | 13 407 660 | |
2019-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 230 000 | 230 000 | |||||
2019-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
A - Award | 70 000 | 70 000 | |||||
2019-01-14 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −36 762 | 160 000 | −18,68 | ||||
2019-01-14 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −36 762 | 2 228 855 | −1,62 | 12,16 | −447 092 | 27 106 889 |
2019-01-14 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 36 762 | 2 265 617 | 1,65 | 6,00 | 220 572 | 13 593 702 | |
2019-01-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −12 895 | 196 762 | −6,15 | ||||
2019-01-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −12 895 | 2 228 855 | −0,58 | 12,00 | −154 771 | 26 751 609 |
2019-01-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 12 895 | 2 241 750 | 0,58 | 6,00 | 77 370 | 13 450 500 | |
2019-01-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −7 275 | 209 657 | −3,35 | ||||
2019-01-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −7 275 | 2 228 855 | −0,33 | 12,04 | −87 599 | 26 837 866 |
2019-01-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 7 275 | 2 236 130 | 0,33 | 6,00 | 43 650 | 13 416 780 | |
2019-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −30 000 | 60 000 | −33,33 | ||||
2019-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −33 333 | 33 334 | −50,00 | ||||
2019-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −33 334 | 0 | −100,00 | ||||
2019-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
F - Taxes | −52 806 | 2 228 855 | −2,31 | 10,91 | −576 113 | 24 316 808 | |
2019-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 30 000 | 2 281 661 | 1,33 | ||||
2019-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 33 333 | 2 251 661 | 1,50 | ||||
2019-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 33 334 | 2 218 328 | 1,53 | ||||
2018-11-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −7 211 | 216 932 | −3,22 | ||||
2018-11-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −7 211 | 2 184 994 | −0,33 | 12,00 | −86 554 | 26 226 701 |
2018-11-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 7 211 | 2 192 205 | 0,33 | 6,00 | 43 266 | 13 153 230 | |
2018-07-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −100 | 224 143 | −0,04 | ||||
2018-07-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −100 | 2 184 994 | 0,00 | 14,10 | −1 410 | 30 808 415 |
2018-07-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 100 | 2 185 094 | 0,00 | 6,00 | 600 | 13 110 564 | |
2018-07-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −10 757 | 224 243 | −4,58 | ||||
2018-07-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −10 757 | 2 184 994 | −0,49 | 14,00 | −150 618 | 30 594 067 |
2018-07-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 10 757 | 2 195 751 | 0,49 | 6,00 | 64 542 | 13 174 506 | |
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (Right to Buy) |
M - Exercise | −27 928 | 235 000 | −10,62 | ||||
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | −27 928 | 2 184 994 | −1,26 | 13,01 | −363 293 | 28 422 839 | |
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 27 928 | 2 212 922 | 1,28 | 6,00 | 167 568 | 13 277 532 | |
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (Right to buy) |
M - Exercise | −30 932 | 262 928 | −10,53 | ||||
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −30 932 | 2 184 994 | −1,40 | 13,00 | −402 150 | 28 407 325 |
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 30 932 | 2 215 926 | 1,42 | 6,00 | 185 592 | 13 295 556 | |
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (Right to buy) |
M - Exercise | −17 798 | 182 202 | −8,90 | ||||
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (Right to buy) |
M - Exercise | −16 140 | 293 860 | −5,21 | ||||
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −17 798 | 2 184 994 | −0,81 | 12,14 | −216 137 | 26 534 349 |
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −16 140 | 2 202 792 | −0,73 | 13,00 | −209 885 | 28 645 107 |
2018-05-23 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 33 938 | 2 218 932 | 1,55 | 6,00 | 203 628 | 13 313 592 | |
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −17 798 | 0 | −100,00 | ||||
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −17 798 | 2 184 994 | −0,81 | 12,14 | −216 137 | 26 534 349 |
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 17 798 | 2 202 792 | 0,81 | 6,00 | 106 788 | 13 216 752 | |
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −82 202 | 17 798 | −82,20 | ||||
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −82 202 | 2 184 994 | −3,63 | 12,26 | −1 007 665 | 26 784 530 |
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 82 202 | 2 267 196 | 3,76 | 6,00 | 493 212 | 13 603 176 | |
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −100 000 | 100 000 | −50,00 | ||||
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −100 000 | 2 184 994 | −4,38 | 11,32 | −1 132 060 | 24 735 443 |
2018-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 100 000 | 2 284 994 | 4,58 | 6,00 | 600 000 | 13 709 964 | |
2018-05-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −32 873 | 200 000 | −14,12 | ||||
2018-05-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −32 873 | 2 184 994 | −1,48 | 11,03 | −362 451 | 24 091 307 |
2018-05-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 32 873 | 2 217 867 | 1,50 | 6,00 | 197 238 | 13 307 202 | |
2018-05-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −17 127 | 232 873 | −6,85 | ||||
2018-05-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −17 127 | 2 184 994 | −0,78 | 11,00 | −188 407 | 24 036 245 |
2018-05-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 17 127 | 2 202 121 | 0,78 | 6,00 | 102 762 | 13 212 726 | |
2018-03-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 290 000 | 290 000 | |||||
2018-03-07 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
A - Award | 90 000 | 90 000 | |||||
2018-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −33 333 | 66 667 | −33,33 | ||||
2018-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −33 333 | 66 667 | −33,33 | ||||
2018-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
F - Taxes | −36 717 | 2 184 994 | −1,65 | 5,95 | −218 466 | 13 000 714 | |
2018-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 33 333 | 2 221 711 | 1,52 | ||||
2018-01-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 33 333 | 2 221 711 | 1,52 | ||||
2017-03-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
A - Award | 100 000 | 100 000 | |||||
2017-03-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 280 000 | 280 000 | |||||
2017-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
M - Exercise | −33 333 | 66 667 | −33,33 | ||||
2017-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
F - Taxes | −17 955 | 2 155 045 | −0,83 | 7,40 | −132 867 | 15 947 333 | |
2017-01-04 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 33 333 | 2 173 000 | 1,56 | ||||
2016-03-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 300 000 | 300 000 | |||||
2016-03-09 |
|
4 | CCXI |
ChemoCentryx, Inc.
Restricted Stock Units |
A - Award | 100 000 | 100 000 | |||||
2016-02-12 |
|
5 | CCXI |
ChemoCentryx, Inc.
Common Stock |
G - Gift | −9 000 | 2 139 667 | −0,42 | ||||
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −6 527 | 0 | −100,00 | ||||
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −6 527 | 2 148 667 | −0,30 | 7,36 | −48 047 | 15 816 768 |
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 6 527 | 2 155 194 | 0,30 | 0,60 | 3 916 | 1 293 116 | |
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −16 540 | 6 527 | −71,70 | ||||
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −16 540 | 2 148 667 | −0,76 | 7,55 | −124 920 | 16 228 022 |
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 16 540 | 2 165 207 | 0,77 | 0,60 | 9 924 | 1 299 124 | |
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −1 200 | 23 067 | −4,94 | ||||
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 200 | 2 148 667 | −0,06 | 7,51 | −9 009 | 16 131 118 |
2015-04-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 1 200 | 2 149 867 | 0,06 | 0,60 | 720 | 1 289 920 | |
2015-03-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −900 | 24 267 | −3,58 | ||||
2015-03-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −900 | 2 148 667 | −0,04 | 7,57 | −6 812 | 16 263 046 |
2015-03-27 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 900 | 2 149 567 | 0,04 | 0,60 | 540 | 1 289 740 | |
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −16 765 | 25 167 | −39,98 | ||||
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −16 765 | 2 148 667 | −0,77 | 7,80 | −130 839 | 16 768 842 |
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 16 765 | 2 165 432 | 0,78 | 0,60 | 10 059 | 1 299 259 | |
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −19 291 | 41 932 | −31,51 | ||||
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −19 291 | 2 148 667 | −0,89 | 7,77 | −149 858 | 16 691 490 |
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 19 291 | 2 167 958 | 0,90 | 0,60 | 11 575 | 1 300 775 | |
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −14 315 | 61 223 | −18,95 | ||||
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −14 315 | 2 148 667 | −0,66 | 8,00 | −114 458 | 17 180 097 |
2015-03-24 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 14 315 | 2 162 982 | 0,67 | 0,60 | 8 589 | 1 297 789 | |
2015-03-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −8 467 | 75 538 | −10,08 | ||||
2015-03-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −8 467 | 2 148 667 | −0,39 | 8,24 | −69 794 | 17 711 677 |
2015-03-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 8 467 | 2 157 134 | 0,39 | 0,60 | 5 080 | 1 294 280 | |
2015-03-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −9 679 | 84 005 | −10,33 | ||||
2015-03-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −9 679 | 2 148 667 | −0,45 | 8,42 | −81 516 | 18 095 859 |
2015-03-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 9 679 | 2 158 346 | 0,45 | 0,60 | 5 807 | 1 295 008 | |
2015-03-18 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −8 590 | 93 684 | −8,40 | ||||
2015-03-18 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −8 590 | 2 148 667 | −0,40 | 8,58 | −73 692 | 18 432 984 |
2015-03-18 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 8 590 | 2 157 257 | 0,40 | 0,60 | 5 154 | 1 294 354 | |
2015-03-18 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −22 726 | 102 274 | −18,18 | ||||
2015-03-18 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −22 726 | 2 148 667 | −1,05 | 8,54 | −194 128 | 18 354 128 |
2015-03-18 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 22 726 | 2 171 393 | 1,06 | 0,60 | 13 636 | 1 302 836 | |
2015-02-25 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 420 000 | 420 000 | |||||
2014-05-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −27 726 | 0 | −100,00 | ||||
2014-05-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −27 726 | 2 148 667 | −1,27 | 5,59 | −154 875 | 12 002 239 |
2014-05-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 27 726 | 2 176 393 | 1,29 | 0,60 | 16 636 | 1 305 836 | |
2014-04-30 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy |
M - Exercise | −14 041 | 27 726 | −33,62 | ||||
2014-04-30 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −14 041 | 2 148 667 | −0,65 | 5,46 | −76 595 | 11 721 193 |
2014-04-30 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 14 041 | 2 162 708 | 0,65 | 0,60 | 8 425 | 1 297 625 | |
2014-04-30 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy |
M - Exercise | −18 233 | 41 767 | −30,39 | ||||
2014-04-30 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −18 233 | 2 148 667 | −0,84 | 5,33 | −97 127 | 11 445 949 |
2014-04-30 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 18 233 | 2 166 900 | 0,85 | 0,60 | 10 940 | 1 300 140 | |
2014-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −20 000 | 60 000 | −25,00 | ||||
2014-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −20 000 | 2 148 707 | −0,92 | 7,25 | −145 000 | 15 578 126 |
2014-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 20 000 | 2 168 707 | 0,93 | 0,60 | 12 000 | 1 301 224 | |
2014-02-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 395 000 | 395 000 | |||||
2014-02-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
M - Exercise | −20 000 | 80 000 | −20,00 | ||||
2014-02-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −20 000 | 2 148 707 | −0,92 | 7,05 | −140 932 | 15 141 079 |
2014-02-20 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
M - Exercise | 20 000 | 2 168 707 | 0,93 | 0,60 | 12 000 | 1 301 224 | |
2013-07-26 |
|
4 | CCXI |
ChemoCentryx, Inc.
Stock Option (right to buy) |
A - Award | 165 000 | 165 000 | |||||
2013-07-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −2 585 | 2 148 687 | −0,12 | 14,54 | −37 595 | 31 249 644 |
2013-07-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −19 504 | 2 151 272 | −0,90 | 14,37 | −280 360 | 30 923 459 |
2013-07-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −311 | 2 170 776 | −0,01 | 14,50 | −4 510 | 31 476 252 |
2013-05-17 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −7 600 | 2 171 087 | −0,35 | 14,04 | −106 728 | 30 489 009 |
2013-04-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −2 312 | 2 178 687 | −0,11 | 14,02 | −32 409 | 30 540 616 |
2013-04-12 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −217 | 2 180 999 | −0,01 | 14,00 | −3 038 | 30 533 986 |
2013-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −200 | 2 181 216 | −0,01 | 14,00 | −2 800 | 30 537 024 |
2013-04-02 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −556 | 2 181 416 | −0,03 | 14,00 | −7 784 | 30 539 824 |
2013-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −75 | 2 181 972 | 0,00 | 13,75 | −1 031 | 30 002 115 |
2013-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −4 215 | 2 182 047 | −0,19 | 14,18 | −59 763 | 30 938 590 |
2013-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 772 | 2 186 262 | −0,08 | 14,11 | −24 998 | 30 841 817 |
2013-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 790 | 2 188 034 | −0,08 | 14,07 | −25 192 | 30 793 296 |
2013-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 649 | 2 189 824 | −0,08 | 14,02 | −23 118 | 30 700 676 |
2013-03-19 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −7 300 | 2 191 473 | −0,33 | 14,07 | −102 721 | 30 837 093 |
2013-03-14 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −422 | 2 198 773 | −0,02 | 14,00 | −5 908 | 30 782 822 |
2013-03-14 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 980 | 2 199 195 | −0,09 | 14,00 | −27 720 | 30 788 730 |
2013-03-14 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −2 503 | 2 201 175 | −0,11 | 14,00 | −35 042 | 30 816 450 |
2013-03-11 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 100 | 2 203 678 | −0,05 | 14,00 | −15 405 | 30 862 070 |
2013-03-11 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 200 | 2 204 778 | −0,05 | 14,00 | −16 804 | 30 874 168 |
2013-03-11 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 573 | 2 205 978 | −0,07 | 14,00 | −22 025 | 30 888 545 |
2013-03-11 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −3 075 | 2 207 551 | −0,14 | 14,00 | −43 050 | 30 905 714 |
2013-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 154 | 2 210 626 | −0,05 | 14,00 | −16 156 | 30 948 764 |
2013-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −105 | 2 211 780 | 0,00 | 14,25 | −1 496 | 31 517 865 |
2013-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −500 | 2 211 885 | −0,02 | 14,03 | −7 016 | 31 034 958 |
2013-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −318 | 2 212 385 | −0,01 | 14,03 | −4 463 | 31 049 939 |
2013-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −400 | 2 212 703 | −0,02 | 14,04 | −5 618 | 31 077 414 |
2013-03-06 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −3 064 | 2 213 103 | −0,14 | 14,00 | −42 896 | 30 983 442 |
2013-03-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −5 982 | 2 216 167 | −0,27 | 13,78 | −82 421 | 30 534 792 |
2013-03-01 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −9 018 | 2 222 149 | −0,40 | 13,50 | −121 743 | 29 999 012 |
2013-02-26 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −7 500 | 2 231 167 | −0,34 | 12,06 | −90 474 | 26 915 014 |
2012-11-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −999 | 2 238 667 | −0,04 | 12,01 | −11 997 | 26 884 152 |
2012-11-21 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −1 101 | 2 239 666 | −0,05 | 12,02 | −13 232 | 26 915 858 |
2012-11-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −2 000 | 2 240 767 | −0,09 | 12,00 | −24 000 | 26 889 204 |
2012-11-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −3 400 | 2 242 767 | −0,15 | 12,18 | −41 423 | 27 324 303 |
2012-11-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −15 000 | 2 246 167 | −0,66 | 12,75 | −191 250 | 28 638 629 |
2012-11-16 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
G - Gift | −18 000 | 2 261 167 | −0,79 | ||||
2012-11-08 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −15 000 | 2 279 167 | −0,65 | 12,01 | −180 160 | 27 374 391 |
2012-11-08 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −7 500 | 2 294 167 | −0,33 | 12,00 | −90 000 | 27 530 004 |
2012-10-03 |
|
4 | CCXI |
ChemoCentryx, Inc.
Common Stock |
S - Sale | X | −15 000 | 2 301 667 | −0,65 | 11,53 | −172 954 | 26 538 911 |
2012-07-26 |
|
4 | CCXI |
ChemoCentryx, Inc.
Employee Stock Option (right to buy) |
A - Award | 485 088 | 485 088 | |||||
2012-02-29 |
|
4 | CCXI |
ChemoCentryx, Inc.
Employee Stock Option (right to buy) |
A - Award | 175 000 | 175 000 | |||||
2012-02-08 | 3 | CCXI |
ChemoCentryx, Inc.
Common Stock |
2 316 667 |